Cme (CME) Payables (2009 - 2026)

Cme (CME) has reported Payables for 18 consecutive years, with $68.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables fell 26.33% year-over-year to $68.0 million in Q2 2026; TTM through Jun 2026 was $68.0 million, a 26.33% decrease from a year earlier, with the FY2025 full-year figure at $71.8 million, down 91.35% from the prior year.
• Payables was $68.0 million for Q2 2026 at Cme, down from $75.4 million in the prior quarter.
• Over five years, Payables peaked at $879.6 million in Q3 2024 and troughed at $50.9 million in Q2 2023.
• A 5-year average of $256.6 million and a median of $91.4 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables surged 1568.76% in 2024 and sank 91.48% in 2025, its largest moves.
• Over 5 years, Payables stood at $137.4 million in 2022, then plunged by 34.06% to $90.6 million in 2023, then soared by 815.78% to $829.7 million in 2024, then plunged by 91.35% to $71.8 million in 2025, then dropped by 5.29% to $68.0 million in 2026.
• The last three Payables figures came in at $68.0 million (Q2 2026), $75.4 million (Q1 2026), and $71.8 million (Q4 2025), per Business Quant data.